Guillain-Barre syndrome after vaccination in United States. A report from the CDC/FDA Vaccine Adverse Event Reporting System

Nizar Souayah; Abu Nasar; M. Fareed K Suri; Adnan I. Qureshi

doi:10.1016/j.vaccine.2007.03.053

Guillain-Barre syndrome after vaccination in United States. A report from the CDC/FDA Vaccine Adverse Event Reporting System

Nizar Souayah
, Abu Nasar
, M. Fareed K Suri
, Adnan I. Qureshi

Neurology

Research output: Contribution to journal › Article › peer-review

71 Scopus citations

Abstract

Using the data from Vaccine Adverse Event Reporting System, we present 54 reports of Guillain-Barre Syndrome (GBS) after vaccination that occurred in United States in 2004. In 38 of the patients, GBS occurred within 6 weeks. The highest number (n = 31) of GBS was observed in patients receiving influenza vaccine followed by hepatitis vaccine (n = 9), 1 patient died and 10 patients were disabled following the event. We conclude that vaccines other than influenza vaccine can be associated with GBS.

Original language	English (US)
Pages (from-to)	5253-5255
Number of pages	3
Journal	Vaccine
Volume	25
Issue number	29
DOIs	https://doi.org/10.1016/j.vaccine.2007.03.053
State	Published - Jul 20 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Adverse event
Guillain-Barre syndrome
Hepatitis vaccine
Influenza vaccine
Vaccination

Publisher link

10.1016/j.vaccine.2007.03.053

Find It

Find It at U of M Libraries

Cite this

@article{9a7e502c9f6146f081ec6ace58269eec,

title = "Guillain-Barre syndrome after vaccination in United States. A report from the CDC/FDA Vaccine Adverse Event Reporting System",

abstract = "Using the data from Vaccine Adverse Event Reporting System, we present 54 reports of Guillain-Barre Syndrome (GBS) after vaccination that occurred in United States in 2004. In 38 of the patients, GBS occurred within 6 weeks. The highest number (n = 31) of GBS was observed in patients receiving influenza vaccine followed by hepatitis vaccine (n = 9), 1 patient died and 10 patients were disabled following the event. We conclude that vaccines other than influenza vaccine can be associated with GBS.",

keywords = "Adverse event, Guillain-Barre syndrome, Hepatitis vaccine, Influenza vaccine, Vaccination",

author = "Nizar Souayah and Abu Nasar and Suri, \{M. Fareed K\} and Qureshi, \{Adnan I.\}",

year = "2007",

month = jul,

day = "20",

doi = "10.1016/j.vaccine.2007.03.053",

language = "English (US)",

volume = "25",

pages = "5253--5255",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Ltd",

number = "29",

}

TY - JOUR

T1 - Guillain-Barre syndrome after vaccination in United States. A report from the CDC/FDA Vaccine Adverse Event Reporting System

AU - Souayah, Nizar

AU - Nasar, Abu

AU - Suri, M. Fareed K

AU - Qureshi, Adnan I.

PY - 2007/7/20

Y1 - 2007/7/20

N2 - Using the data from Vaccine Adverse Event Reporting System, we present 54 reports of Guillain-Barre Syndrome (GBS) after vaccination that occurred in United States in 2004. In 38 of the patients, GBS occurred within 6 weeks. The highest number (n = 31) of GBS was observed in patients receiving influenza vaccine followed by hepatitis vaccine (n = 9), 1 patient died and 10 patients were disabled following the event. We conclude that vaccines other than influenza vaccine can be associated with GBS.

AB - Using the data from Vaccine Adverse Event Reporting System, we present 54 reports of Guillain-Barre Syndrome (GBS) after vaccination that occurred in United States in 2004. In 38 of the patients, GBS occurred within 6 weeks. The highest number (n = 31) of GBS was observed in patients receiving influenza vaccine followed by hepatitis vaccine (n = 9), 1 patient died and 10 patients were disabled following the event. We conclude that vaccines other than influenza vaccine can be associated with GBS.

KW - Adverse event

KW - Guillain-Barre syndrome

KW - Hepatitis vaccine

KW - Influenza vaccine

KW - Vaccination

UR - https://www.scopus.com/pages/publications/34250810715

UR - https://www.scopus.com/pages/publications/34250810715#tab=citedBy

U2 - 10.1016/j.vaccine.2007.03.053

DO - 10.1016/j.vaccine.2007.03.053

M3 - Article

C2 - 17560693

AN - SCOPUS:34250810715

SN - 0264-410X

VL - 25

SP - 5253

EP - 5255

JO - Vaccine

JF - Vaccine

IS - 29

ER -

Guillain-Barre syndrome after vaccination in United States. A report from the CDC/FDA Vaccine Adverse Event Reporting System

Abstract

UN SDGs

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this